$43.68
+0.48 (+1.11%)
Open$43.39
Previous Close$43.20
Day High$44.09
Day Low$43.23
52W High$50.81
52W Low$15.86
Volume—
Avg Volume754.4K
Market Cap2.15B
P/E Ratio—
EPS$-1.98
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+3.8% upside
Current
$43.68
$43.68
Target
$45.36
$45.36
$37.53
$45.36 avg
$61.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 111.25M | 93.11M | 574.93M |
| Net Income | -155,544,584 | -117,166,158 | 29.33M |
| Profit Margin | -139.8% | -132.8% | 5.1% |
| EBITDA | -126,221,204 | -100,360,013 | 65.79M |
| Free Cash Flow | — | — | 30.48M |
| Rev Growth | +19.5% | +19.5% | -7.8% |
| Debt/Equity | — | — | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |